NCCPF No:- 450050
Catalogue Information : |
|||||
Candida | parapsilosis | ||||
450050 | |||||
Senders Details : |
|||||
PGIMER, Chandigarh | NA | ||||
PGIMER, Chandigarh | NA | ||||
31-Dec-2019 | |||||
5856 | |||||
MALDI Based Identification : |
|||||
Candida parapsilosis | 2.40 | ||||
02-Jan-2020 | |||||
DNA Sequencing Based Identification : |
|||||
Candida parapsilosis | ITS | ||||
99% | 04-Nov-2022 | ||||
1667551992_450050_1.pdf | 450050 | ||||
Candida parapsilosis | |||||
ANTIFUNGAL SUSCEPTIBILITY TESTING (AFST) CLSI METHOD : |
|||||
Yeast | none | ||||
Candida parapsilosis | |||||
1 | Micafungin | 2.000 | Sensitive | ||
2 | Fluconazole | 16.000 | Resistant | ||
3 | Voriconazole | 0.125 | Sensitive | ||
4 | Itraconazole | 0.250 | Sensitive | ||
5 | posaconazole | 0.125 | Sensitive | ||
6 | Amphotericin B | 2.000 | Resistant | ||
7 | Caspofungin | 2.000 | Sensitive | ||
8 | Anindulifungin | 2.000 | Sensitive |